Category: Life Sciences
Global Life Sciences
-
Biotechnology
... of 8.4% over the analysis period 2023-2030. DNA Sequencing Market, one of the segments analyzed in the report, is expected to record a 8.6% CAGR and reach US$33.5 Billion by the end of the analysis ... Read More
-
Fibrin Sealants
... at a CAGR of 6.0% over the analysis period 2023-2030. Liquid Sealants, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$1.2 Billion by the end of ... Read More
-
Synthetic Antioxidants
... at a CAGR of 6.0% over the analysis period 2023-2030. Liquid Synthetic Antioxidants, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$2.4 Billion by the end ... Read More
-
Topical Dressings
... at a CAGR of 10.0% over the analysis period 2023-2030. Burn Wounds Application, one of the segments analyzed in the report, is expected to record a 8.9% CAGR and reach US$467.4 Million by the end ... Read More
-
Interferon
... of 2.7% over the analysis period 2023-2030. Interferon Beta, one of the segments analyzed in the report, is expected to record a 3.1% CAGR and reach US$4.6 Billion by the end of the analysis period. ... Read More
-
Endoscope Reprocessing
... at a CAGR of 7.8% over the analysis period 2023-2030. High-Level Disinfectants & Test Strips, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$1.4 Billion by ... Read More
-
Surgical Procedures
... at a CAGR of 2.0% over the analysis period 2023-2030. Dental Procedures, one of the segments analyzed in the report, is expected to record a 1.8% CAGR and reach US$31.6 Billion by the end of ... Read More
-
Blood Transfusion Diagnostics
... by 2030, growing at a CAGR of 4.7% over the analysis period 2023-2030. Blood Transfusion Diagnostic Instruments, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$1.7 ... Read More
-
Endoscopy Equipment
... at a CAGR of 6.1% over the analysis period 2023-2030. Endoscopes, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$37.5 Billion by the end of the ... Read More
-
Exosome Research Products
... by 2030, growing at a CAGR of 20.6% over the analysis period 2023-2030. Kits & Reagents, one of the segments analyzed in the report, is expected to record a 22.3% CAGR and reach US$697.8 Million ... Read More
-
Microelectronic Medical Implants
... by 2030, growing at a CAGR of 8.2% over the analysis period 2023-2030. Pacemakers & Defibrillators, one of the segments analyzed in the report, is expected to record a 8.6% CAGR and reach US$20.6 Billion ... Read More
-
Mid-Revenue Cycle Management / Clinical Documentation Improvement
... US$5.1 Billion in the year 2023, is expected to reach US$8.0 Billion by 2030, growing at a CAGR of 6.7% over the analysis period 2023-2030. Solutions Component, one of the segments analyzed in the report, ... Read More
-
Pharmacovigilance
... of 9.2% over the analysis period 2023-2030. Contract Outsourcing, one of the segments analyzed in the report, is expected to record a 11.1% CAGR and reach US$12.3 Billion by the end of the analysis period. ... Read More
-
General Surgery Devices
... by 2030, growing at a CAGR of 5.9% over the analysis period 2023-2030. Adhesion Prevention Products, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$14.6 Billion ... Read More
-
Microtomes
... of 5.9% over the analysis period 2023-2030. Microtome Instruments, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$162.8 Million by the end of the analysis period. ... Read More
-
Near Infrared Imaging
... by 2030, growing at a CAGR of 14.6% over the analysis period 2023-2030. Near Infrared Imaging Devices, one of the segments analyzed in the report, is expected to record a 13.5% CAGR and reach US$1.7 ... Read More
-
Produce Packaging Trays
... by 2030, growing at a CAGR of 4.1% over the analysis period 2023-2030. Growers / Shippers End-Use, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$2.0 ... Read More
-
Latent TB Testing Market by Test Type (Tuberculin Skin Test/TST, IGRA Test), Application (Household Contacts (HHC) of Tuberculosis (TB) Patients, People Living with HIV), End User (Diagnostic Labs, Hospitals), Region - Global Forecast to 2029
... The latent TB testing market will rise in value from estimated USD 582.5 million in 2024 to USD 773.4 million in 2029, at a CAGR of 5.8% over the forecast period. Increased funding and grants ... Read More
-
Legionella Testing
... at a CAGR of 8.2% over the analysis period 2023-2030. Culture Methods, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$122.4 Million by the end of ... Read More
-
Medical Connectors
... at a CAGR of 5.7% over the analysis period 2023-2030. Hospital & Clinics End-Use, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$2.7 Billion by the ... Read More
-
Real-time PCR (qPCR) and Digital PCR (dPCR)
... US$5.6 Billion in the year 2023, is expected to reach US$8.4 Billion by 2030, growing at a CAGR of 6.1% over the analysis period 2023-2030. Quantitative Technology, one of the segments analyzed in the report, ... Read More
-
Therapeutic Respiratory Devices
... by 2030, growing at a CAGR of 3.4% over the analysis period 2023-2030. Positive Airway Pressure Devices, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$32.3 ... Read More
-
Micromanipulators
... of 15.0% over the analysis period 2023-2030. Electric Micromanipulators, one of the segments analyzed in the report, is expected to record a 16.0% CAGR and reach US$134.2 Million by the end of the analysis period. ... Read More
-
Healthcare Information Systems
... by 2030, growing at a CAGR of 11.4% over the analysis period 2023-2030. Web-based Healthcare Information Systems, one of the segments analyzed in the report, is expected to record a 10.5% CAGR and reach US$396.5 ... Read More
-
Implantable Drug Delivery Devices
... reach US$41.2 Billion by 2030, growing at a CAGR of 6.1% over the analysis period 2023-2030. Contraceptive Implants, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach ... Read More
Research Assistance
